Staar Surgical Co. (STAA)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: OPHTHALMIC GOODS

1911 WALKER AVE MONROVIA, CA 91016

Staar Surgical Co. develops, manufactures and distributes medical devices for use in minimally invasive refractive, cataract and glaucoma surgery. Products include foldable intraocular lenses, implantable contact lenses, the Sonic WAVE phacoemulsification system and the AquaFlow Collagen Glaucoma Drainage Device.

Data as of 2020-08-09
Market Cap2.481 Billion Shares Outstanding45.806 Million Avg 30-day Volume675.722 Thousand
P/E Ratio344.9 Dividend Yield EPS0.16
Price/Sales16.727 Price cash flow ratio186.1 Price free cash flow ratio681.2
Book Value3.81 Price to Tangible Book14.37 Alpha0.03
Short Interest Ratio % Short Interest to Float R-squared0.117573
BETA1.57528 52-week High/Low62.51 / 23.2 Stddev0.193188
View SEC Filings from STAA instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 5 5 (0.33%)
13F Filers holding this stock: 155 62 (4.06%)
Aggregate 13F shares on 03/31/2020: 41.642 Million 25.265 Million
Aggregate 13F shares on 12/31/2019: 42.281 Million 25.378 Million
Percent change: -1.51% -0.45%
Funds creating new positions: 28 14
Funds Adding to an existing position: 53 17
Funds closing out their position: 31 10
Funds reducing their position: 56 22
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding STAA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding STAA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

80.8 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

80.8 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HAYASHIDA JON K. VP, GLOBAL CLINICAL, MEDICAL

  • Officer
10,794 2020-08-10 4

WILLIAMS PATRICK F. CHIEF FINANCIAL OFFICER

  • Officer
30,727 2020-08-10 2

MOORE JOHN C

  • Director
160,835 2020-07-30 3

SILVERMAN LOU

  • Director
27,613 2020-07-30 1

FARRELL STEPHEN C

  • Director
5,808 2020-07-30 1

KLIMAN GILBERT H

  • Director
2,581 2020-07-30 3

FRINZI THOMAS G

  • Director
2,117 2020-07-30 3

BAILEY DON M

  • Director
0 2020-07-01 0

ANDREWS DEBORAH J

  • Director
0 2020-07-01 3

BROADWOOD PARTNERS, L.P.

BRADSHER NEAL C

BROADWOOD CAPITAL INC

  • 10% Owner
21,616,596 2020-07-01 2

BLICKENSDOERFER HANS-MARTIN SR. VP, COMM. OPS, CHINA

  • Officer
127,950 2020-06-15 4

MEIER RICHARD A

  • Director
84,340 2020-05-27 0

GESTEN SAMUEL J CHIEF LEGAL OFFICER

  • Officer
41,185 2020-05-21 2

HOLLIDAY KEITH CHIEF TECHNOLOGY OFFICER

  • Officer
28,447 2020-05-15 3

SLACIK CHARLES P

  • Director
11,352 2020-05-14 0

FRANCESE JAMES E SR. VP, COMM. OPS., NA, APAC

  • Officer
51,133 2020-05-11 2

HANSEN GRAYDON C. SR. VP, GLOBAL OPERATIONS

  • Officer
21,553 2020-05-11 3

MASON CAREN L PRESIDENT & CEO

  • Officer
  • Director
0 2020-03-20 1

BARNES SCOTT D CHIEF MEDICAL OFFICER

  • Officer
20,390 2020-03-20 2

WALL WILLIAM P

  • Director
18,824 2020-02-05 1

ROUSH JACK STEVEN

  • Director
0 2019-03-20 0

BROWN STEPHEN P VP, CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2017-04-28 0

LOGAN MARK B

  • Director
46,696 2015-07-08 0

HUGHES ROBIN VICE PRESIDENT, R&D

  • Officer
41,075 2015-04-07 0

CALDWELL BARRY G

  • Director
309,839 2014-06-09 0

TUNSTALL KATHRYN

  • Director
6,085 2014-06-09 0

CONCEPTUS INC

  • Director
0 2014-01-30 0

SUBRIN PHILIPPE VICE PRESIDENT, SWITZERLAND OP

  • Officer
56,500 2013-03-04 0

GOODMEN WILLIAM WALTER GLOBAL VP, HUMAN RESOURCES

  • Officer
15,000 2012-08-20 0

TODD DONALD J PRESIDENT, ASIA/PACIFIC

  • Officer
7,500 2012-06-07 0

FELBERG CRAIG VP, R&D AND CLINICAL AFFAIRS

  • Officer
8,700 2012-06-05 0

DUFFY DONALD

  • Director
57,000 2012-05-14 0

FAGEN DONALD L V.P. SALES FOR N. AMERICA

  • Officer
9,300 2012-03-02 0

MORRISON DAVID R

  • Director
40,000 2011-12-01 0

KAUFMAN CHARLES S V.P. , GENERAL COUNSEL

  • Officer
33,500 2011-08-26 0

KAMIJO ISAMU PRESIDENT, STAAR JAPAN INC.

  • Officer
23,334 2010-12-06 0

BAILEY DAVID PRESIDENT, INT'L OPERATIONS

  • Officer
  • Director
1,140,000 2010-03-05 0

CURTIS NICHOLAS T SR. VP SALES AND MARKETING

  • Officer
0 2008-05-15 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

WILLIAMS PATRICK F. - Officer CHIEF FINANCIAL OFFICER

2020-08-10 A 30,727 a 30,727 30,727.00 direct

HAYASHIDA JON K. - Officer VP, GLOBAL CLINICAL, MEDICAL

2020-08-10 M 5,822 d 0 10,794.00 direct

HAYASHIDA JON K. - Officer VP, GLOBAL CLINICAL, MEDICAL

2020-08-10 M 8,000 $16.15 a 52,396 10,794.00 direct

HAYASHIDA JON K. - Officer VP, GLOBAL CLINICAL, MEDICAL

2020-08-10 M 16,206 $9.30 a 27,000 10,794.00 direct

HAYASHIDA JON K. - Officer VP, GLOBAL CLINICAL, MEDICAL

2020-08-10 M 8,000 d 6,476 10,794.00 direct

HAYASHIDA JON K. - Officer VP, GLOBAL CLINICAL, MEDICAL

2020-08-10 M 16,206 d 0 10,794.00 direct

HAYASHIDA JON K. - Officer VP, GLOBAL CLINICAL, MEDICAL

2020-08-10 M 11,574 $8.64 a 44,396 10,794.00 direct

HAYASHIDA JON K. - Officer VP, GLOBAL CLINICAL, MEDICAL

2020-08-10 M 11,574 d 0 10,794.00 direct

HAYASHIDA JON K. - Officer VP, GLOBAL CLINICAL, MEDICAL

2020-08-10 S 41,602 $51.22 d 10,794 10,794.00 direct

HAYASHIDA JON K. - Officer VP, GLOBAL CLINICAL, MEDICAL

2020-08-10 M 5,822 $7.52 a 32,822 10,794.00 direct

KLIMAN GILBERT H - Director

2020-07-30 A 2,117 a 2,581 2,581.00 direct

FARRELL STEPHEN C - Director

2020-07-30 A 2,117 a 5,808 5,808.00 direct

MOORE JOHN C - Director

2020-07-30 A 2,117 a 2,117 160,835.00 direct

SILVERMAN LOU - Director

2020-07-30 A 2,117 a 15,850 27,613.00 direct

FRINZI THOMAS G - Director

2020-07-30 A 2,117 a 2,117 2,117.00 direct

BROADWOOD PARTNERS, L.P. - > 10% Owner

BRADSHER NEAL C - > 10% Owner

BROADWOOD CAPITAL INC - > 10% Owner

2020-07-01 J 4,062 d 10,795,348 21,616,596.00 direct

BLICKENSDOERFER HANS-MARTIN - Officer SR. VP, COMM. OPS, CHINA

2020-06-15 M 19,215 $11.00 a 147,165 127,950.00 direct

BLICKENSDOERFER HANS-MARTIN - Officer SR. VP, COMM. OPS, CHINA

2020-06-15 S 39,215 $44.07 d 127,950 127,950.00 direct

BLICKENSDOERFER HANS-MARTIN - Officer SR. VP, COMM. OPS, CHINA

2020-06-15 M 20,000 d 0 127,950.00 direct

BLICKENSDOERFER HANS-MARTIN - Officer SR. VP, COMM. OPS, CHINA

2020-06-15 M 20,000 $5.34 a 167,165 127,950.00 direct

BLICKENSDOERFER HANS-MARTIN - Officer SR. VP, COMM. OPS, CHINA

2020-06-15 M 19,215 d 0 127,950.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments